Literature DB >> 24795715

Familial hemophagocytic lymphohistiocytosis: when rare diseases shed light on immune system functioning.

Elena Sieni1, Valentina Cetica2, Yvonne Hackmann3, Maria Luisa Coniglio1, Martina Da Ros1, Benedetta Ciambotti1, Daniela Pende4, Gillian Griffiths3, Maurizio Aricò5.   

Abstract

The human immune system depends on the activity of cytotoxic T lymphocytes (CTL), natural killer (NK) cells, and NKT cells in order to fight off a viral infection. Understanding the molecular mechanisms during this process and the role of individual proteins was greatly improved by the study of familial hemophagocytic lymphohistiocytosis (FHL). Since 1999, genetic sequencing is the gold standard to classify patients into different subgroups of FHL. The diagnosis, once based on a clinical constellation of abnormalities, is now strongly supported by the results of a functional flow-cytometry screening, which directs the genetic study. A few additional congenital immune deficiencies can also cause a resembling or even identical clinical picture to FHL. As in many other rare human disorders, the collection and analysis of a relatively large number of cases in registries is crucial to draw a complete picture of the disease. The conduction of prospective therapeutic trials allows investigators to increase the awareness of the disease and to speed up the diagnostic process, but also provides important functional and genetic confirmations. Children with confirmed diagnosis may undergo hematopoietic stem cell transplantation, which is the only cure known to date. Moreover, detailed characterization of these rare patients helped to understand the function of individual proteins within the exocytic machinery of CTL, NK, and NKT cells. Moreover, identification of these genotypes also provides valuable information on variant phenotypes, other than FHL, associated with biallelic and monoallelic mutations in the FHL-related genes. In this review, we describe how detailed characterization of patients with genetic hemophagocytic lymphohistiocytosis has resulted in improvement in knowledge regarding contribution of individual proteins to the functional machinery of cytotoxic T- and NK-cells. The review also details how identification of these genotypes has provided valuable information on variant phenotypes.

Entities:  

Keywords:  cellular cytotoxicity; hemophagocytosis; mutation analysis; natural killer

Year:  2014        PMID: 24795715      PMCID: PMC3997030          DOI: 10.3389/fimmu.2014.00167

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  186 in total

1.  Perforin A91V polymorphism and putative susceptibility to hematological malignancies.

Authors:  S Muralitharan; Y Wali; A V Pathare
Journal:  Leukemia       Date:  2006-10-12       Impact factor: 11.528

2.  XIAP Q423P polymorphism and susceptibility to childhood hemophagocytic lymphohistiocytosis.

Authors:  Dan-Yan Ou; Jian-Ming Luo; Yuan Yuan
Journal:  Pediatr Blood Cancer       Date:  2013-08-16       Impact factor: 3.167

3.  Perforin defects of primary haemophagocytic lymphohistiocytosis in Japan.

Authors:  Naohiro Suga; Hidetoshi Takada; Akihiko Nomura; Shouichi Ohga; Eiichi Ishii; Kenji Ihara; Koichi Ohshima; Toshiro Hara
Journal:  Br J Haematol       Date:  2002-02       Impact factor: 6.998

4.  Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation.

Authors:  Rebecca A Marsh; Gretchen Vaughn; Mi-Ok Kim; Dandan Li; Sonata Jodele; Sarita Joshi; Parinda A Mehta; Stella M Davies; Michael B Jordan; Jack J Bleesing; Alexandra H Filipovich
Journal:  Blood       Date:  2010-09-20       Impact factor: 22.113

Review 5.  Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome.

Authors:  W Introne; R E Boissy; W A Gahl
Journal:  Mol Genet Metab       Date:  1999-10       Impact factor: 4.797

6.  A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin.

Authors:  Christina Trambas; Federico Gallo; Daniela Pende; Stefania Marcenaro; Lorenzo Moretta; Carmela De Fusco; Alessandra Santoro; Luigi Notarangelo; Maurizio Arico; Gillian M Griffiths
Journal:  Blood       Date:  2005-03-01       Impact factor: 22.113

Review 7.  Linking albinism and immunity: the secrets of secretory lysosomes.

Authors:  Jane Stinchcombe; Giovanna Bossi; Gillian M Griffiths
Journal:  Science       Date:  2004-07-02       Impact factor: 47.728

8.  Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients.

Authors:  Nizar Mahlaoui; Marie Ouachée-Chardin; Geneviève de Saint Basile; Bénédicte Neven; Capucine Picard; Stéphane Blanche; Alain Fischer
Journal:  Pediatrics       Date:  2007-08-14       Impact factor: 7.124

9.  Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients.

Authors:  Yenan T Bryceson; Eva Rudd; Chengyun Zheng; Josefine Edner; Daoxin Ma; Stephanie M Wood; Anne Grete Bechensteen; Jaap J Boelens; Tiraje Celkan; Roula A Farah; Kjell Hultenby; Jacek Winiarski; Paul A Roche; Magnus Nordenskjöld; Jan-Inge Henter; Eric O Long; Hans-Gustaf Ljunggren
Journal:  Blood       Date:  2007-05-24       Impact factor: 22.113

10.  Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11.

Authors:  Udo zur Stadt; Jan Rohr; Wenke Seifert; Florian Koch; Samantha Grieve; Julia Pagel; Julia Strauss; Brigitte Kasper; Gudrun Nürnberg; Christian Becker; Andrea Maul-Pavicic; Karin Beutel; Gritta Janka; Gillian Griffiths; Stephan Ehl; Hans Christian Hennies
Journal:  Am J Hum Genet       Date:  2009-10       Impact factor: 11.025

View more
  38 in total

Review 1.  Lysosome-related organelles as functional adaptations of the endolysosomal system.

Authors:  Cédric Delevoye; Michael S Marks; Graça Raposo
Journal:  Curr Opin Cell Biol       Date:  2019-06-22       Impact factor: 8.382

2.  CD8 T Cell Memory Increases Immunopathology in the Perforin-Deficient Model of Hemophagocytic Lymphohistiocytosis Secondary to TNF-α.

Authors:  Matthew D Taylor; Thomas N Burn; E John Wherry; Edward M Behrens
Journal:  Immunohorizons       Date:  2018-02

3.  Specific sequences of infectious challenge lead to secondary hemophagocytic lymphohistiocytosis-like disease in mice.

Authors:  Andrew Wang; Scott D Pope; Jason S Weinstein; Shuang Yu; Cuiling Zhang; Carmen J Booth; Ruslan Medzhitov
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-23       Impact factor: 11.205

4.  A CD57+ CTL Degranulation Assay Effectively Identifies Familial Hemophagocytic Lymphohistiocytosis Type 3 Patients.

Authors:  Masayuki Hori; Takahiro Yasumi; Saeko Shimodera; Hirofumi Shibata; Eitaro Hiejima; Hirotsugu Oda; Kazushi Izawa; Tomoki Kawai; Masataka Ishimura; Naoko Nakano; Ryutaro Shirakawa; Ryuta Nishikomori; Hidetoshi Takada; Satoshi Morita; Hisanori Horiuchi; Osamu Ohara; Eiichi Ishii; Toshio Heike
Journal:  J Clin Immunol       Date:  2016-11-28       Impact factor: 8.317

5.  Mouse model for acute Epstein-Barr virus infection.

Authors:  Tristan Wirtz; Timm Weber; Sven Kracker; Thomas Sommermann; Klaus Rajewsky; Tomoharu Yasuda
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-16       Impact factor: 11.205

Review 6.  Molecular regulation of the plasma membrane-proximal cellular steps involved in NK cell cytolytic function.

Authors:  Prasad V Phatarpekar; Daniel D Billadeau
Journal:  J Cell Sci       Date:  2020-02-21       Impact factor: 5.285

Review 7.  [Hemophagocytic lymphohistiocytosis : A diagnostic challenge on the ICU].

Authors:  G Lachmann; P La Rosée; T Schenk; F M Brunkhorst; C Spies
Journal:  Anaesthesist       Date:  2016-10       Impact factor: 1.041

Review 8.  Emapalumab for the treatment of relapsed/refractory hemophagocytic lymphohistiocytosis.

Authors:  Mounica Vallurupalli; Nancy Berliner
Journal:  Blood       Date:  2019-11-21       Impact factor: 22.113

9.  Cytomorphologic Features Found in Cerebrospinal Fluid Specimens of Hemophagocytic Lymphohistiocytosis Patients.

Authors:  Susan Shyu; Dragos Luca; Christopher J VandenBussche; Cheng-Ying Ho
Journal:  Am J Clin Pathol       Date:  2021-08-04       Impact factor: 2.493

Review 10.  Pathologically Relevant Mouse Models for Epstein-Barr Virus-Associated B Cell Lymphoma.

Authors:  Shiyu Huang; Tomoharu Yasuda
Journal:  Front Immunol       Date:  2021-02-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.